Infigen, Inc. provides biotechnology research services. It develops xenotransplantation technology to allow animal organs to be transplanted into humans. The company's products are used in various therapeutic applications including surgery, trauma, cancer therapy, urinary & fecal incontinence, and cosmetic reconstruction. The firm was founded in 1997 and is headquartered in DeForest, WI

eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Konkuk University Industry-Academic Cooperation Foundation increases the competitiveness of industries by linking company and university.

Henan Chuangyuan Biotechnology Co., Ltd., established on 2016-09-29, Business scope includes biotechnology research,Technology Promotion,technical consulting,Technical Services;Sales:Laboratory Instruments and Reagents,Consumables,veterinary medicine,feed;Import and export of goods or technology..

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Provides biotechnology and research services and develops cell therapy technology

BioTransplant, Inc. is a life science company. The company discovers, develops and commercializes therapeutics, therapeutic devices and therapeutic regimens designed to suppress undesired immune responses and enhance the body's ability to accept donor cells, tissues and organs. The company was founded on March 20, 1990 and is headquartered in Charlestown, MA.

Stem Cell Sciences is a research and development company that focuses on stem cells. The company was established in April 2002.

National Livestock Breeding Center is a Japanese private company located in Fukushima that provides livestock breeding services.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Jiangsu Academy of Agricultural Sciences is a Chinese private company located in Nanjing, with subsidiaries in China, that engages in agriculture research and development.

Hua Pai Sheng Wu Ji Shu （ Ji Tuan ） Gu Fen You Xian Gong Si, established on 2008-12-17, Business scope includes veterinary biological products,chemical preparation,Chinese medicine preparation,Chinese patent medicine,Antibody preparation,disinfectant,Production of daily chemical products,research and development,Sales,Technical Services,Technology transfer,import and export trade(Except for trades that are restricted by the state and prohibited from import and export);Agency sales of veterinary biological products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

University of Missouri Board of Curators is an American private company located in Columbia, MO, focused on colleges, universities, and professional schools.

Harbin Aopuke Agricultural Biotechnology Co., Ltd., established on 2017-07-19, Business scope includes biotechnology extension services,animal breeding,General Cargo Warehousing Services(Free of Hazardous Chemicals,easy drug).

Guangdong Tianyi New Material Technology Co., Ltd., established on 2010-10-29, Business scope includes research and development,design,production and marketing,processing:Eco-environmental material,High Performance Membrane Materials;Import and export,Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Henan Greenkins Biotechnology Co., Ltd., established on 2013-06-26, Business scope includes biotechnology development,consult,comminicate,transfer,Promotion service;Import and export of goods or technology;Sales:wine,Pre-packaged food,Electrical Equipment,primary agricultural products,farming equipment.

AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden.

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany.